Addressing Nocturia in Older Women Utilizing Behavioral Sleep Intervention and Brief Mindfulness

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age65+
SponsorUniversity of Pittsburgh

About this trial

The goal of this clinical trial is to examine and compare the effect of behavioral sleep treatment: BBTI (brief behavioral treatment of insomnia) and brief mindfulness (MI), independently and combined vs control on frequency of nighttime awakenings to void (nocturia) and on nighttime urine production in older women over the age 65 years with nocturia.

To study the effect of these treatments, participants will be randomly assigned to one of the following groups 1) BBTI alone, 2) MI alone, 3) BBTI+MI, or 4) control: sleep information only without any structured sleep or mindfulness therapy.

The study aims to examine the effect of these therapies at end-of-treatment (week 4), as well sustained effects at 3- and 6-months. The main questions the study aims to answer are:

1. do these treatments reduce the frequency of nighttime awakenings to void 2. do these treatments reduce the volume of nighttime urine production 3. do these treatments improve sleep quality

Frequency of nocturia and sleep quality will be assessed via questionnaires and nighttime urine volume using bladder-sleep diaries which is 3-day record participants will complete at home documenting every time they go to the bathroom and volume they voided. In addition, sleep and sleep interruptions will also be assessed using an FDA-cleared home sleep testing device called Zmachine®.

Eligibility criteria

Qualifiers

Female

Age > or =65 years

Nocturia ≥2/night

Poor sleep (Insomnia Severity Index ≥8)

Disqualifiers

Conditions that affect bladder function: Multiple sclerosis, Alzheimer's disease, spinal cord injury, urethral obstruction, urinary retention, interstitial cystitis, bladder cancer, radiation to the pelvic area, bladder surgery, current or uncontrolled chronic or recurrent bowel issues, bacterial endocarditis

cardiac or respiratory disease that limits daily function

Untreated, current, severe psychiatric condition (assessed during Visit 1a- medical history)

Post void residual ≥ 200ml- assessed during baseline visit

Trial design

Treatments tested in this trial

  • Brief behavioral treatment of insomnia
  • MI
  • Control
  • BBTI+MI

Treatment groups

80 Participants
are divided into 4 treatment groups

Sponsors and collaborators

University of Pittsburgh

Lead sponsor

National Institute on Aging (NIA)

Collaborator